The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. | Generate:Biomedicines is the latest biotech to benefit from a ...
Hosted on MSN
Getting In on IPOs Is Getting Easier
Ordinary investors who worry about missing out on a warming initial public offering market should take a deep breath. Their chances of getting shares are improving. Shares in an IPO have long been a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results